Additionally, the intricate chemokine receptor 7 (CCR7) chemokine axis, characterized by chemokine ligand 21 (CCL21) and CCL19, has emerged as a promising avenue in cancer immunotherapy. This evidence concerns the gene CCL21 and cancer.